Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Plenful Announces Referral Agent, the First Agent for 340B, Built to Capture Meaningful 340B Referral Savings at Scale

Plenful Logo

News provided by

Plenful

Jun 10, 2026, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Plenful's Referral Agent applies advanced LLMs to investigate unstructured EHR data at a scale no manual process can match. At a leading Mid-Atlantic academic medical center, Referral Agent expanded referral claim review from 130 claims per month to 12,700 - a 98x capacity increase. At more than $1,850 in average 340B savings recaptured per claim, the impact compounds with every future fill.

SAN FRANCISCO, June 10, 2026 /PRNewswire/ -- Plenful, the leading AI workflow automation platform for pharmacy teams, today announced the launch of Referral Agent, following deployments with major health systems. Referral Agent is the first AI solution purpose-built to identify and capture referral-based savings hidden in unstructured clinical documentation.

Continue Reading
Referral Agent acts as a force multiplier for 340B teams.
Referral Agent acts as a force multiplier for 340B teams.

A single 340B referral claim can be worth more than $1,850 in recaptured savings — value that compounds across every future fill. Referral Agent reviews tens of thousands of claims each month, recovering savings that would otherwise go uncaptured.

The 340B Drug Pricing Program covers nearly 50% of U.S. hospitals, generating billions in savings that fund care for underserved patients. For most covered entities, referral capture is one of the largest untapped savings opportunities within 340B, and one of the hardest to operationalize. Without AI automation, pharmacy teams manually dig through fragmented referral and clinical documentation, including notes, free-text fields, and faxes, scattered across multiple systems. Traditional third-party administrator (TPA) matching logic surfaces only discretely coded data, leaving the majority of real-world evidence undiscovered. Manual chart review is expensive, inconsistent, and nearly impossible to scale across the thousands of claims large health systems process each month. Most programs have never attempted a systematic referral capture strategy - the operational lift is simply too high.

Plenful's Referral Agent acts as a force multiplier for 340B teams. Using large language models (LLMs) trained on clinical language, the agent analyzes both structured and unstructured EHR data - including clinical notes, PDFs, and other documentation - to find referrals and match them to downstream claims. Results are ranked by drug cost and specialty, so 340B teams can prioritize the highest-value opportunities. Every finding includes the source document, extracted evidence, and a confidence signal, giving pharmacy teams an auditable record defensible in an HRSA audit.

For external referrals where encounter data lives outside the EHR, Referral Agent traces prescription claims, recovering scripts that would otherwise remain invisible to covered entities.

Plenful's Referral Agent enables pharmacy teams to:

  • Uncover millions in missed 340B savings. Recover referral-based claims that manual processes couldn't reach. With average recapture exceeding $1,850 per claim, and covered entities reviewing thousands of claims per month, the impact adds up quickly.
  • Significantly scale referral review. Automate the scanning of clinical notes, summaries, and PDFs to uncover referral evidence that's often missed by manual review. At a leading Mid-Atlantic academic medical center, Referral Agent expanded referral claim review from 130 claims per month to 12,700 - a 98x capacity increase.
  • Act on ranked, high-confidence findings. Prioritize flagged claim review by drug cost and referral specialty to optimize for high-value work. Plenful customers report, on average, an 82% accuracy rate on flagged claims.
  • Close the loop on referral documentation. Automatically generate and send referral documentation back to the referring provider via major EHRs. Referral Agent closes the documentation loop to build a defensible, HRSA-ready evidence record for every captured referral.
  • Gain visibility into external referrals. Trace contract pharmacy claims to attribute referrals that exist entirely outside the health system's EHR.

"One of our partners went from reviewing 130 referral claims a month to 12,700 — not by adding staff, but by letting AI do the work that was never possible to do manually," said Joy Liu, Founder and CEO of Plenful. "Most 340B programs aren't running a referral capture strategy at all — not because the savings weren't real, but because finding informal referrals buried in clinical notes is an infinite task. Referral Agent changes the equation entirely. It expands what your team can pursue beyond formal orders alone and makes a strategy that was too cost-prohibitive to run manually not just possible, but scalable."

Referral Agent expands Plenful's 340B Audit and Optimization suite - trusted by 95+ healthcare organizations - giving pharmacy, compliance, and finance teams a comprehensive platform to protect and grow their 340B programs. To learn more about Plenful's AI workflow automation platform for 340B optimization, revenue optimization, and expanded intake authorization solutions for infusion and specialty pharmacy teams, visit Plenful.com.

About Plenful
Plenful is on a mission to move pharmacy forward through intelligent automation. As the leading AI automation platform purpose-built for pharmacy teams, Plenful eliminates administrative burden, enhances compliance, and unlocks sustainable growth. By combining deep pharmacy expertise with enterprise-grade AI, Plenful automates complex workflows across intake authorization, 340B management, reconciliation management, and more. Plenful partners with more than 95 leading health systems, infusion practices, pharmacies, and healthcare organizations nationwide to power smarter, faster, and more resilient pharmacy operations. To learn more, visit Plenful.com.

Plenful Media Contact:
Morgan Chaney-Arnold
Head of Marketing at Plenful
[email protected]

SOURCE Plenful

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Plenful Unveils MFP "Command Center" to Help Health Systems Recover Up to 20% in Missing Medicare Drug Price Refunds

Plenful Unveils MFP "Command Center" to Help Health Systems Recover Up to 20% in Missing Medicare Drug Price Refunds

Plenful, the leading AI workflow automation platform for pharmacy teams, today announced the launch of its MFP Intelligence solution, following...

Plenful Unveils AI Suite to Automate Intake and Prior Authorization, Accelerating Patient Care and Slashing Admin Work by 75%

Plenful Unveils AI Suite to Automate Intake and Prior Authorization, Accelerating Patient Care and Slashing Admin Work by 75%

Plenful, the leading AI workflow automation platform modernizing healthcare, today announced its Intake Authorization Management Suite. Built to end...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

Computer Software

Computer Software

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.